Understanding non-small cell lung cancer information

American Cancer Society material can provide general background, but it cannot select treatment for an individual. Decisions require the biopsy findings, scans, breathing and general health assessments, molecular test results when relevant, and the person's goals.

Non-small cell lung cancer, often shortened to NSCLC, includes adenocarcinoma, squamous cell carcinoma, and other less common subtypes. A biopsy identifies the subtype. Staging describes the original lung tumour, lymph node involvement, and whether cancer has spread elsewhere.

Biomarker testing looks for tumour features that may predict benefit from a targeted medicine or help guide immunotherapy. The amount and quality of biopsy tissue can affect which tests are possible, so occasionally another sample or a blood-based tumour test is considered.

Ask for the exact subtype and stage in plain language and whether all relevant biomarker results are available before systemic treatment begins. Smoking cessation support is worthwhile after diagnosis because stopping can improve breathing and the body's ability to tolerate treatment.

A localised tumour may be treated with lung surgery, such as lobectomy, or stereotactic body radiotherapy when surgery is unsuitable. More extensive disease may call for immunotherapy, targeted therapy when a matching biomarker is present, chemotherapy, radiotherapy, or combinations. Symptom control and palliative care can accompany any plan.

Report a new or worsening cough, increasing breathlessness, coughing up blood, persistent chest pain, new hoarseness, unexplained weakness, or treatment side effects to your clinical team. The cause may require examination, imaging, blood tests, or treatment adjustment.

Seek emergency help for severe breathing difficulty, a large amount of coughed-up blood, sudden chest pain, fainting, new confusion, a seizure, or sudden weakness on one side of the body.

What subtype and stage do I have? Is there enough tissue for biomarker testing? Is treatment intended to remove the cancer, reduce recurrence risk, control growth, or relieve symptoms? How will my lung function influence the choice?